Importantly, the inhibition of HA in lupus-prone mice improved disease parameters, at least partially by reducing the expression of pro-inflammatory cytokines, including IL-1β, TNFα, and IL-6, in the kidney (57). This evidence concerns the gene IL1B and systemic lupus erythematosus.